Alosetron
CAS No. 122852-42-0
Alosetron( GR-68755X | GR-68755 )
Catalog No. M10888 CAS No. 122852-42-0
A potent and selective 5-HT3 receptor antagonist has been shown to be beneficial in the treatment of irritable bowel syndrome.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 1078 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAlosetron
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective 5-HT3 receptor antagonist has been shown to be beneficial in the treatment of irritable bowel syndrome.
-
DescriptionA potent and selective 5-HT3 receptor antagonist has been shown to be beneficial in the treatment of irritable bowel syndrome.Irritable Bowel Syndrome Approved.
-
In Vitro——
-
In VivoDexamethasone and Alosetron-treated (1 mg/kg; ip; daily for 6 days) rats exhibits a significant decrease in the diarrhea index, in comparison with TNBS-control group, especially after the initial 2 days of treatment following the induction of colitis.
-
SynonymsGR-68755X | GR-68755
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research AreaOther Indications
-
IndicationIrritable Bowel Syndrome
Chemical Information
-
CAS Number122852-42-0
-
Formula Weight294.351
-
Molecular FormulaC17H18N4O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCc1c([nH]cn1)CN2CCc3c(c4ccccc4n3C)C2=O
-
Chemical Name1H-Pyrido[4,3-b]indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Audolfsson G, et al. Aliment Pharmacol Ther. 1999 May;13 Suppl 2:39-47.
2. Zhai J, et al. J Pharmacol Exp Ther. 1999 Oct;291(1):374-82.
3. Saslow SB, et al. Gut. 1998 May;42(5):628-34.
molnova catalog
related products
-
Org-13011 fumarate
Org-13011 fumarate1 is an agonist of the 5-HT1A receptor and can be used to study neurological disorders.
-
Minesapride
Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
-
LY 272015 hydrochlor...
LY 272015 hydrochloride is an orally active and selective 5-HT2B receptor antagonist that displays antihypertensive effects in DOCA-salt hypertensive rats.
Cart
sales@molnova.com